本页面由Tiger Trade Technology Pte. Ltd.提供服务

CRISPR Therapeutics AG

40.19
+0.04000.10%
盘后:40.510.3200+0.80%19:56 EST
成交量:397.93万
成交额:1.62亿
市值:38.86亿
市盈率:-8.44
高:42.66
开:40.25
低:40.10
收:40.15
52周最高:63.45
52周最低:39.80
股本:9,669.26万
流通股本:9,420.30万
量比:1.47
换手率:4.22%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
净资产收益率:-25.60%
总资产收益率:-13.49%
市净率:2.36
市盈率(LYR):-6.21

数据加载中...

2026/11/17

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/02

重要事件披露

Form 8-K - Current report
2026/10/19

重要事件披露

Form 8-K - Current report
2026/10/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]